companydata.dkcompanydata.dk

NORDIC BIOTECH HOLDING ApS: Financial statements 2022

CVR: 26409683

Source: annual report 2022, Danish Business Authority

01/01/2022 – 31/12/2022

NORDIC BIOTECH HOLDING ApS (CVR 26409683) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 113,606 and a net result of DKK 95,776 compared with DKK 305,283 the year before. That is a decrease of 65% compared with the year before. Equity in the 2022 report amounted to DKK 853,699. The solvency ratio was 77.1%. The company had 1 employee in the financial year.

Gross Profit
DKK 113,606
Profit/Loss
DKK 95,776
Equity
DKK 853,699
Total Assets
DKK 1,106,995
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022-114K96K854K1
2021-325K305K758K1
2020-442K325K-462K1
2019--697K-688K-788K-
2018--169K-292K-100K-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on NORDIC BIOTECH HOLDING ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

NORDIC BIOTECH HOLDING ApS: The 2021 annual report is outJul 19, 2022

NORDIC BIOTECH HOLDING ApS has published its annual report for 2021. Gross profit came to DKK 324,716, and the net result was DKK 305,283.

About NORDIC BIOTECH HOLDING ApS

NORDIC BIOTECH HOLDING ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2001. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named SN BIOTECH HOLDING ApS. The management consists of Torsten Bjørn. The company is owned by FINANSMANAGEMENT ApS. The company has 1 employee (2012). In 2025, the company reported a gross profit of DKK -39,555 and a net result of DKK -7,860 compared with DKK -39,278 the year before. Equity in the 2025 report amounted to DKK 139,260.

Source: annual report 2025, Danish Business Authority